The Longevity Research Institute
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Strong fit as a capital/intermediary target because the evidence explicitly frames it around venture philanthropy for drug discovery and helping donors fund research that can translate into real drugs entering the clinic. OpenDrugs is positioned as research infrastructure for longevity therapeutics discovery, making this a relevant financing or partnership lead.